HYBRID EVENT: Join us in person in Barcelona, Spain or attend virtually from anywhere.

10th Edition of World Congress on Infectious Diseases

June 25-27, 2026 | Barcelona, Spain

June 25 -27, 2026 | Barcelona, Spain
Infection 2026

Coagulopathy, a hidden enemy in persistent organ dysfunction in post-septic rats

Speaker at Infectious Diseases Conferences - Yolanda Prado
Universidad Andres Bello, Chile
Title : Coagulopathy, a hidden enemy in persistent organ dysfunction in post-septic rats

Abstract:

Background: Post-sepsis syndrome (PSS) affects up to 50% of survivors, with a mortality exceeding 82% at 5 years and annual costs exceeding $100 billion only in the United States. While immune dysregulation has dominated PSS research, coagulopathy emerges as a silent but critical driver of post-sepsis sequelae. However, mechanisms, biomarkers, and subsequently, therapies targeting PSS remain poorly characterized.

Objective: To evaluate the contribution of coagulopathy to organ dysfunction during the post-sepsis period.

Methods: Male Sprague-Dawley rats received Salmonella enterica serovar Typhi outer membrane vesicles (OMVs) (n=17) or saline solution (n=11). Animals were euthanized at three temporal phases: acute (6h), survivor (6d), and post-sepsis (20d) periods. Thirty-two parameters, including coagulation, renal, hepatic, immune, and metabolic markers were normalized as Z-scores against reference intervals from thirty untreated rats. An adapted SOFA score was used to define organ dysfunction. The predictive role of coagulopathy and associated markers was analyzed through relative risk (Fisher's exact), ROC/AUC, and logistic regression.

Results: OMVs induced organ dysfunction in 100% of animals at 6h (p=0.029) and 80% at 20d (p=0.048) versus 0% saline. SOFA trajectory showed a non-linear pattern, with 100% of animals presenting organ dysfunction at 6h, then a partial recovery at 6d, and re-emergence at 20d. INR independently predicted organ dysfunction (OR=6.6 [95%CI: 1.0–43.4], p=0.049; AUC=0.903). Thrombocytopenia was the most persistent alteration on post-sepsis period (Cliff's δ=−1.0 at 20d), suggesting active platelet consumption by ongoing thrombus formation. Immune markers (LYMPHO% AUC=0.938; SEGMEN% AUC=0.920) and glucose (AUC=0.912) emerged as strong predictors of organ dysfunction, potentially attributable to NET formation, lymphocyte exhaustion, and hyperglycemia, possibly amplifying endothelial dysfunction and perpetuating the coagulopathic state.

Conclusions: Coagulopathy, specifically through elevated INR and thrombocytopenia, is associated with organ dysfunction during the post-sepsis period. Immune and metabolic dysregulation could act as amplifiers of these alterations. The S. Typhi OMVs model represents a robust platform for evaluating biomarkers and therapeutic strategies in post-sepsis syndrome.

Biography:

Yolanda Prado is a biologist and Doctor in Molecular Biosciences. Currently a postdoctoral researcher at Universidad Andrés Bello, Chile. Her work focuses in three research lines: the pathophysiology of post-infectious sequelae, with a current focus on coagulopathy and organ dysfunction in post-sepsis syndrome; diagnostic and therapeutic innovation with a gender perspective in infectious diseases; and epidemiological surveillance of post-infectious sequelae at the territorial level

Watsapp